Literature DB >> 29054894

Mucopolysaccharidosis type IVA (Morquio A): a close differential diagnosis of spondylo-epiphyseal dysplasia.

Sugata Narayan Biswas1, Shinjan Patra1, Partha Pratim Chakraborty1, Himanshu Barman1.   

Abstract

Patients with mucopolysaccharidoses (MPS) have a plethora of multisystemic manifestations depending on the particular type, and atypical presentations are not uncommon. MPS type IVA (Morquio A syndrome) has predominant musculoskeletal system involvement and corneal clouding with normal intelligence and can be misdiagnosed as primary skeletal disorders in clinical practice. The absence of corneal clouding with normal urinary glycosaminoglycans (GAGs) level in a proportion of patients with MPS IVA makes the correct diagnosis even more challenging for physicians. Healthcare providers across specialties should have a high degree of suspicion for MPS IVA in all patients with suspected spondylo-epiphyseal dysplasia as early diagnosis and early treatment significantly improve the clinical outcome and activity of daily living. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  general practice / family medicine; metabolic disorders; musculoskeletal syndromes; orthopaedics; rehabilitation medicine

Mesh:

Substances:

Year:  2017        PMID: 29054894      PMCID: PMC5665360          DOI: 10.1136/bcr-2017-221156

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Cumulative incidence rates of the mucopolysaccharidoses in Germany.

Authors:  F Baehner; C Schmiedeskamp; F Krummenauer; E Miebach; M Bajbouj; C Whybra; A Kohlschütter; C Kampmann; M Beck
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  [Ocular manifestations in patients affected by Morquio syndrome (MPS IV)].

Authors:  J Couprie; P Denis; N Guffon; N Reynes; H Masset; F Beby
Journal:  J Fr Ophtalmol       Date:  2010-11-03       Impact factor: 0.818

3.  Optimizing the molecular diagnosis of GALNS: novel methods to define and characterize Morquio-A syndrome-associated mutations.

Authors:  Anna Caciotti; Rodolfo Tonin; Miriam Rigoldi; Lorenzo Ferri; Serena Catarzi; Catia Cavicchi; Elena Procopio; Maria Alice Donati; Anna Ficcadenti; Agata Fiumara; Rita Barone; Livia Garavelli; Maja Di Rocco; Mirella Filocamo; Daniela Antuzzi; Maurizio Scarpa; Sean D Mooney; Biao Li; Anastasia Skouma; Sebastiano Bianca; Daniela Concolino; Rosario Casalone; Elena Monti; Marilena Pantaleo; Sabrina Giglio; Renzo Guerrini; Rossella Parini; Amelia Morrone
Journal:  Hum Mutat       Date:  2015-03       Impact factor: 4.878

Review 4.  Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review.

Authors:  H Northover; R A Cowie; J E Wraith
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 5.  Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.

Authors:  H S Scott; S Bunge; A Gal; L A Clarke; C P Morris; J J Hopwood
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

6.  Hematopoietic stem cell transplantation for Morquio A syndrome.

Authors:  Hiromasa Yabe; Akemi Tanaka; Yasutsugu Chinen; Shunichi Kato; Kazuki Sawamoto; Eriko Yasuda; Haruo Shintaku; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2015-10-01       Impact factor: 4.797

7.  Overcoming the barriers to diagnosis of Morquio A syndrome.

Authors:  Kaustuv Bhattacharya; Shanti Balasubramaniam; Yew Sing Choy; Michael Fietz; Antony Fu; Dong Kyu Jin; Ok-Hwa Kim; Motomichi Kosuga; Young Hee Kwun; Anita Inwood; Hsiang-Yu Lin; Jim McGill; Nancy J Mendelsohn; Torayuki Okuyama; Hasri Samion; Adeline Tan; Akemi Tanaka; Verasak Thamkunanon; Teck-Hock Toh; Albert D Yang; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

Review 8.  A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases.

Authors:  Regina M Leadley; Shona Lang; Kate Misso; Trudy Bekkering; Janine Ross; Takeyuki Akiyama; Michael Fietz; Roberto Giugliani; Chris J Hendriksz; Ngu Lock Hock; Jim McGill; Andrew Olaye; Mohit Jain; Jos Kleijnen
Journal:  Orphanet J Rare Dis       Date:  2014-11-18       Impact factor: 4.123

9.  30 months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: About one case.

Authors:  J Do Cao; A Wiedemann; T Quinaux; S F Battaglia-Hsu; L Mainard; R Froissart; C Bonnemains; S Ragot; B Leheup; P Journeau; F Feillet
Journal:  Mol Genet Metab Rep       Date:  2016-10-10

10.  Unresolving short stature in a possible case of mucopolysccharidosis.

Authors:  Ac Ayuk; Ho Obu; Md Ughasoro; Ns Ibeziako
Journal:  Ann Med Health Sci Res       Date:  2014-03
View more
  2 in total

Review 1.  Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.

Authors:  Kazuki Sawamoto; Molly Stapleton; Carlos J Alméciga-Díaz; Angela J Espejo-Mojica; Juan Camilo Losada; Diego A Suarez; Shunji Tomatsu
Journal:  Drugs       Date:  2019-07       Impact factor: 11.431

2.  Modeling Morquio A Syndrome: An Anthropometric Study of Body Characteristics and Stature.

Authors:  Agnieszka Różdżyńska-Świątkowska; Krzysztof Szklanny; Jolanta Marucha; Anna Tylki-Szymańska
Journal:  Diagnostics (Basel)       Date:  2020-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.